stars 1 stars 2 stars 3

Bioxodes is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of therapeutics for patients with thrombo-inflammatory diseases. We leverage our deep understanding of the thrombotic and inflammatory processes to design novel product candidates with an aim to address unmet medical needs.

View Top Employees from Bioxodes
Website http://www.bioxodes.com
Revenue $1 million
Employees 14 (14 on RocketReach)
Founded 2013
Phone (327) 123-9600
Technologies
Industry Biotechnology, Manufacturing General, Pharmaceuticals, Manufacturing, Science and Engineering, Drug Discovery, Health Care, Therapeutics
SIC SIC Code 283 Companies, SIC Code 28 Companies
NAICS NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies

Bioxodes Questions

The Bioxodes annual revenue was $1 million in 2024.

Hans-Christiaan Warrinnier is the Chief Medical Officer of Bioxodes.

14 people are employed at Bioxodes.

The NAICS codes for Bioxodes are [325, 32541, 32, 3254].

The SIC codes for Bioxodes are [283, 28].

Top Bioxodes Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users